One of the wholly owned subsidiary of Sun Pharmaceutical Industries has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58 percent fully diluted equity stake on conversion) by way of allotment.

scpharmaceuticals Inc which is a United States Pharmaceutical company and develops a portfolio of trans formative pharmaceutical products for subcutaneous delivery.

Read EquityPandit’s Technical Analysis on Nifty Pharma